Development and validation of tools for predicting the risk of death and ICU admission of non-HIV-infected patients with Pneumocystis jirovecii pneumonia

INTRODUCTION: The mortality rate of non-HIV-infected Pneumocystis jirovecii pneumonia (PCP) is high. This research aimed to develop and validate two clinical tools for predicting the risk of death and intensive care unit (ICU) admission in non-HIV-infected patients with PCP to reduce mortality. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Fan, Liang, Hao, Chen, Wen-can, Xie, Jing, Wang, Huan-ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679649/
https://www.ncbi.nlm.nih.gov/pubmed/36424963
http://dx.doi.org/10.3389/fpubh.2022.972311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679649/
https://www.ncbi.nlm.nih.gov/pubmed/36424963
http://dx.doi.org/10.3389/fpubh.2022.972311

Ejemplares similares